Connection

DAVID GRAHAM to Risk

This is a "connection" page, showing publications DAVID GRAHAM has written about Risk.
Connection Strength

0.423
  1. Toward Quantification of H pylori-associated Gastric Cancer Risk: Further Evidence Supporting Development of Population-based Strategies for H pylori Eradication. Gastroenterology. 2024 02; 166(2):248-249.
    View in: PubMed
    Score: 0.179
  2. Eradication of gastric cancer is now both possible and practical. Semin Cancer Biol. 2013 Dec; 23(6 Pt B):492-501.
    View in: PubMed
    Score: 0.088
  3. Helicobacter pylori is not and never was "protective" against anything, including GERD. Dig Dis Sci. 2003 Apr; 48(4):629-30.
    View in: PubMed
    Score: 0.043
  4. Risk stratification for gastric cancer after Helicobacter pylori eradication: A population-based study on Matsu Islands. J Gastroenterol Hepatol. 2021 Mar; 36(3):671-679.
    View in: PubMed
    Score: 0.036
  5. Acute pancreatitis with long-term celecoxib vs. ibuprofen or naproxen: data from the PRECISION trial. Am J Gastroenterol. 2018 07; 113(7):1053-1054.
    View in: PubMed
    Score: 0.031
  6. Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis. N Engl J Med. 2016 12 29; 375(26):2519-29.
    View in: PubMed
    Score: 0.028
  7. Variceal hemorrhage: a critical evaluation of survival analysis. Gastroenterology. 1982 May; 82(5 Pt 1):968-73.
    View in: PubMed
    Score: 0.010
  8. Endoscopic complications: the Texas experience. Gastrointest Endosc. 1979 Nov; 25(4):146-9.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.